We are live on ! Find out more
RXST icon

RxSight

163 hedge funds and large institutions have $382M invested in RxSight in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more call options, than puts

Call options by funds: $499K | Put options by funds: $179K

28% more capital invested

Capital invested by funds: $299M → $382M (+$83.3M)

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

7.96% more ownership

Funds ownership: 81.24%89.2% (+8%)

2% more funds holding

Funds holding: 160163 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 56

Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
34
Increased
56
Reduced
56
Closed
27
Calls
$499K
Puts
$179K
Net Calls
+$320K
Net Calls Change
+$345K

RXST Hedge Fund Activity: Q4 2025 in Review

163 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2025, worth a combined $382M — up 28% from $299M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new RXST positions and 27 closed out — a net gain of 7 holders — while 56 added to existing stakes and 56 trimmed.

The largest buyer was Nomura Holdings, opening a new position worth an estimated $20.1M. The largest seller was 4D Advisors, exiting entirely with an estimated $4.99M sold.

  • 163 institutional investors held RxSight (RXST) as of Q4 2025, up from 160 in Q3 2025.
  • Funds reported $382M of RxSight stock for Q4 2025, up 28% quarter-over-quarter.
  • 34 funds opened new RxSight positions in Q4 2025 and 27 closed out, a net change of +7 holders.
  • The largest RxSight buyer in Q4 2025 was Nomura Holdings, an estimated $20.1M added.
  • The largest RxSight seller in Q4 2025 was 4D Advisors, an estimated $4.99M sold.

Based on aggregated 13F filings for Q4 2025.